Paulsen Gisela 4

4 · Oncocyte Corp · Filed Dec 20, 2022

Form 4

Period: 2022-12-16

Former President and COO

Transactions

Disposition to Issuer
Option to Purchase Common Stock
2022-12-16−70,313→ 54,687 total
Exercise: $1.15→ Common Stock (70,313 underlying)
Disposition to Issuer
Common Stock, no par value
2022-12-01−175,000→ 366,500 total
Disposition to Issuer
Option to Purchase Common Stock
2022-12-16−171,875→ 203,125 total
Exercise: $3.42→ Common Stock (171,875 underlying)
Disposition to Issuer
Option to Purchase Common Stock
2022-12-16−125,000→ 0 total
Exercise: $1.15→ Common Stock (125,000 underlying)

Footnotes (2)

[F1]The restricted stock units were forfeited by mutual agreement of the Reporting Person and the Issuer in connection with a severance agreement entered into as a result of the Reporting Person's resignation as an officer and director of the Issuer on December 16, 2022. Any remaining restricted stock units immediately vested on December 16, 2022.
[F2]The options were forfeited by mutual agreement of the Reporting Person and the Issuer in connection with a severance agreement entered into as a result of the Reporting Person's resignation as an officer and director of the Issuer on December 16, 2022. Any remaining options immediately vested and became exercisable as of December 16, 2022.

Documents

1 file